Ensartinib in Non-small Cell Lung Cancer Patients With Positive ALK

Clinical trial NCT02959619 · COMPLETED

Trial details

NCT number: NCT02959619
Sponsor: Betta Pharmaceuticals Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Non-Small Cell Lung Cancer Metastatic

Start date: 2017-03-06
Primary completion: 2019-10-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.